Country: Malaysia
Language: English
Source: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
CASPOFUNGIN ACETATE
MERCK SHARP & DOHME (MALAYSIA) SDN BHD
CASPOFUNGIN ACETATE
10ml mL
LABORATOIRES MERCK SHARP & DOHME - CHIBRET
EUPPI-CAN-IV-012007 EN EMEA/H/C/379/N031 1 dec 2006 PACKAGE LEAFLET: INFORMATION FOR THE USER CANCIDAS 50 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION CASPOFUNGIN (AS ACETATE) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. • Keep this leaflet. You may need to read it again. • If you have further questions, please ask your doctor or your pharmacist. • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: 1. What CANCIDAS is and what it is used for 2. Before you take CANCIDAS 3. How to take CANCIDAS 4. Possible side effects 5. How to store CANCIDAS 6. Further information 1. WHAT CANCIDAS IS AND WHAT IT IS USED FOR CANCIDAS is an antifungal medicine that interferes with the production of a component (glucan polysaccharide) of the fungal cell wall that is necessary if the fungus is to continue living and growing. Fungal cells exposed to CANCIDAS have incomplete or defective cell walls, making them fragile and unable to grow. CANCIDAS may have been prescribed to treat a serious fungal infection called invasive candidiasis. The infection is caused by fungal (yeast) cells called _Candida_ . These yeast cells are normally found in the digestive tract, and do not cause an infection unless they enter the bloodstream (in which case the infection is referred to as candidaemia) or other tissues or organs, such as the lining of the abdomen (peritonitis), the heart, the kidneys, the liver, bones, muscles, joints, spleen, or eyes. Persons at high risk for invasive candidiasis include surgical patients and those whose immune systems are deficient. Fever and chills that do not respond to antibacterial therapy are the most common symptoms of this type of infection. Alternatively, your doctor may have prescribed CANCIDAS to treat a fungal infection in y Read the complete document
LPC -MK0991 -IV -102016 -Malaysia LOCAL PRODUCT CIRCULAR CANCIDAS ® (caspofungin acetate) FOR INJECTION I. THERAPEUTIC CLASS CANCIDAS ® is a sterile, lyophilized product for intravenous infusion that contains a semi - synthetic lipopeptide (echinocan din) compound synthesized from a fermentation product of Glarea lozoyensis. CANCIDAS is the first of a new class of antifungal drugs (echinocandins) that inhibit the synthesis of β (1,3) -D-glucan, an integral component of the fungal cell wall. CANCIDAS (caspofungin acetate) is 1 -[(4 R,5S)-5-[(2 -aminoethyl)amino] -N2-(10,12 -dimethyl - 1-oxotetradecyl) -4-hydroxy -L-ornithine] -5-[(3 R)-3-hydroxy -L-ornithine]pn eumocandin B 0 diacetate (salt). In addition to the active ingredient caspofungin acetate, CANCIDAS contains the following inactive ingredients: sucrose, mannitol, acetic acid, and sodium hydroxide. Caspofungin acetate is a hygroscopic, white to off -white p owder. It is freely soluble in water and methanol, and slightly soluble in ethanol. The pH of a saturated aqueous solution of caspofungin acetate is approximately 6.6. The empirical formula is C 52H88N10O15• 2C 2H4O2 and the formula weight is 1213.42. The structural formula is: O H N N H H N O H H N O N H C H 3 O H O H N N H H O N H O O H O O H O O O O H 3 C C H 3 C H 3 H 2 N H O H 2 N • 2 C H 3 C O 2 H Read the complete document